Institutional Experience of Using Andexanet Alfa

Given their ease of use, safety, and efficacy, direct-acting oral anticoagulants (DOACs) are nowadays widely used in patients with atrial fibrillation or venous thromboembolism, with or without an association with malignancy. Andexanet alfa (andexanet) is a recombinant modified human factor Xa decoy...

Descripción completa

Detalles Bibliográficos
Autores principales: Khadka, Sushmita, Kasireddy, Vineela, Dhakal, Pravash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Hematology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425824/
https://www.ncbi.nlm.nih.gov/pubmed/32802609
http://dx.doi.org/10.7759/cureus.9173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425824/
https://www.ncbi.nlm.nih.gov/pubmed/32802609
http://dx.doi.org/10.7759/cureus.9173

Ejemplares similares